Kaken Pharmaceutical: ［Delayed］［Summary］Consolidated Financial Results for the Third Quarter of Fiscal 2023 (Nine-Month Period Ended December 31, 2023) [JGAAP]

JPX · Feb 13 16:45

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.